Bank of New York Mellon’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$420K Buy
427,057
+11,916
+3% +$11.7K ﹤0.01% 3586
2025
Q1
$598K Sell
415,141
-12,391
-3% -$17.8K ﹤0.01% 3341
2024
Q4
$941K Buy
427,532
+1,758
+0.4% +$3.87K ﹤0.01% 3184
2024
Q3
$703K Sell
425,774
-146,549
-26% -$242K ﹤0.01% 3325
2024
Q2
$1.27M Buy
572,323
+555,382
+3,278% +$1.23M ﹤0.01% 3053
2024
Q1
$45.4K Sell
16,941
-48,193
-74% -$129K ﹤0.01% 4080
2023
Q4
$195K Buy
65,134
+37,738
+138% +$113K ﹤0.01% 3957
2023
Q3
$26.8K Sell
27,396
-162
-0.6% -$159 ﹤0.01% 4212
2023
Q2
$38.3K Sell
27,558
-257,382
-90% -$358K ﹤0.01% 4204
2023
Q1
$453K Sell
284,940
-1,346
-0.5% -$2.14K ﹤0.01% 3536
2022
Q4
$1.78M Buy
286,286
+13,880
+5% +$86.5K ﹤0.01% 2912
2022
Q3
$1.83M Buy
272,406
+31,217
+13% +$209K ﹤0.01% 2917
2022
Q2
$1.53M Buy
241,189
+16,967
+8% +$108K ﹤0.01% 2980
2022
Q1
$1.04M Buy
224,222
+112,894
+101% +$524K ﹤0.01% 3289
2021
Q4
$557K Buy
111,328
+19,279
+21% +$96.5K ﹤0.01% 3738
2021
Q3
$1.11M Buy
92,049
+8,292
+10% +$99.9K ﹤0.01% 3330
2021
Q2
$1.77M Sell
83,757
-17,535
-17% -$371K ﹤0.01% 3068
2021
Q1
$2.84M Sell
101,292
-16,725
-14% -$469K ﹤0.01% 2718
2020
Q4
$3.07M Sell
118,017
-18,056
-13% -$470K ﹤0.01% 2597
2020
Q3
$5.06M Sell
136,073
-1,406
-1% -$52.3K ﹤0.01% 2211
2020
Q2
$7.05M Buy
137,479
+240
+0.2% +$12.3K ﹤0.01% 2033
2020
Q1
$4.33M Sell
137,239
-15,513
-10% -$489K ﹤0.01% 2147
2019
Q4
$9.11M Buy
152,752
+50,621
+50% +$3.02M ﹤0.01% 2029
2019
Q3
$3.74M Sell
102,131
-2,116
-2% -$77.5K ﹤0.01% 2418
2019
Q2
$4.85M Buy
104,247
+1,114
+1% +$51.8K ﹤0.01% 2346
2019
Q1
$4.14M Sell
103,133
-1,072
-1% -$43K ﹤0.01% 2424
2018
Q4
$4.79M Sell
104,205
-13,591
-12% -$625K ﹤0.01% 2324
2018
Q3
$5.23M Buy
117,796
+6,212
+6% +$276K ﹤0.01% 2385
2018
Q2
$4.37M Sell
111,584
-30,335
-21% -$1.19M ﹤0.01% 2468
2018
Q1
$10.3M Buy
141,919
+25,695
+22% +$1.86M ﹤0.01% 1965
2017
Q4
$7.65M Buy
116,224
+852
+0.7% +$56.1K ﹤0.01% 2121
2017
Q3
$5.78M Buy
115,372
+519
+0.5% +$26K ﹤0.01% 2277
2017
Q2
$5.32M Buy
114,853
+10,250
+10% +$474K ﹤0.01% 2301
2017
Q1
$3.69M Buy
104,603
+23,740
+29% +$838K ﹤0.01% 2484
2016
Q4
$1.01M Buy
80,863
+19,543
+32% +$245K ﹤0.01% 3258
2016
Q3
$849K Sell
61,320
-898
-1% -$12.4K ﹤0.01% 3261
2016
Q2
$615K Sell
62,218
-1,395
-2% -$13.8K ﹤0.01% 3425
2016
Q1
$1.08M Buy
63,613
+1,823
+3% +$30.8K ﹤0.01% 3011
2015
Q4
$1.38M Buy
61,790
+1,420
+2% +$31.6K ﹤0.01% 2945
2015
Q3
$1.42M Sell
60,370
-23,698
-28% -$559K ﹤0.01% 2942
2015
Q2
$6.87M Buy
84,068
+14,662
+21% +$1.2M ﹤0.01% 2164
2015
Q1
$6.43M Sell
69,406
-23,728
-25% -$2.2M ﹤0.01% 2180
2014
Q4
$3.77M Buy
93,134
+34,132
+58% +$1.38M ﹤0.01% 2464
2014
Q3
$1.44M Buy
59,002
+4,981
+9% +$122K ﹤0.01% 3084
2014
Q2
$856K Buy
54,021
+2,734
+5% +$43.3K ﹤0.01% 3400
2014
Q1
$775K Buy
51,287
+38,810
+311% +$586K ﹤0.01% 3402
2013
Q4
$171K Buy
12,477
+1,841
+17% +$25.2K ﹤0.01% 3860
2013
Q3
$200K Buy
+10,636
New +$200K ﹤0.01% 3768